Flavored Non-Fructose Compositions and Methods for Negating Dehydration

Abstract

Embodiments of the present invention are directed to ingredients, formulations, methods of manufacture and use of an oral rehydration solution (“ORS”) in the prevention and treatment of dehydration in humans. More specifically, invention embodiments relate to flavored electrolyte drink mixtures that relieve the dehydrating effects caused by travel, exercise, over-indulgence of toxic substances, and various illnesses in individual subjects. An ORS embodiment of the present invention restores fluid and electrolyte balance in humans as fast and as effectively as IV therapy, and thereby reduces the incidence of dehydration in human populations as well as rehydrating individuals in circumstances where IV therapy is not practical or wanted. The disclosed ORS therapies and packs may be used in conjunction with IV therapy as a multi-part strategy to allow hospitals to lower patient re-admission rates, lower staffing needs, give outpatient self-therapy to treatments prescribed outside of the hospital environment, and thus lower treatment and process costs while not reducing system or treatment efficacy.

Claims

1. A flavored low osmolarity fructose-free solution to be used by an individual in need of hydration, said use comprising: a) providing: i) a fine dry particle powder produced by mixing, grinding, crushing, or disintegrating one or more compounds including dextrose, sodium citrate, sodium chloride, potassium chloride, zinc gluconate, citric acid, ascorbic acid, sucralose, beta carotene, natural flavoring additive; and ii) silicon dioxide or at least one compound drying excipient; iii) mixing said dry powder into natural or manufactured water to form a solution; and b) further comprising orally administering a predetermined dose of said flavored low osmolarity solution to said individual in need of hydration in a manner such that hydration is achieved and low osmolarity is maintained.

2. A personal hydration pack, comprising the compound ingredients of claim 1.

3. A personal hydration pack of claim 2, wherein the compound ingredients of claim 1 are delivered to the individual orally or through a fluid delivery device.

4. A personal hydration kit given to an individual in need of hydration, and to compliment that individual's IV therapy, comprising a low osmolarity and flavored solution that contains no fructose.

5. A medical kit for on-site hydration for an individual in need, comprising the compound ingredients of claim 1.

6. The orally administered solution of claim 1, wherein the total osmolarity value is below 210 mOsm/L.

Description

EXAMPLE I

[0012] Ingredients from one exemplary fructose-free embodiment of the present invention with suggested serving size of dry composition (without water or liquid added). The inventors contemplate other embodiments from the formula below.

TABLE-US-00001 Composition Ingredient Mg. input range per serving Ascorbic acid 150 mg-250 mg. Zinc Gluconate  5 mg-75 mg. Dextrose 4000 mg-6000 mg. Sodium Chloride  750 mg-1500 mg. Potassium Chloride  500 mg-1000 mg. Sodium Citrate 1200 mg-1600 mg. Citric Acid 1400 mg-2000 mg. Natural Flavoring Additive 3000 mg-4000 mg. Sucralose 30 mg-75 mg. Anato or Beta Carotene  5 mg-20 mg.
Exemplary Dry Serving Size (Mg) would be within range of above ingredients.

Breadth of Embodiments and Equlevants

[0013] In addition to the rehydration flavor formulations disclosed above, other non-fructose flavor enhancers or sweeteners are contemplated that relate to sugars, including a combination of sugars, such as glucose, sucrose, leucrose, trehalose, galactose, isomaltulose, dextrose, maltodextrin, corn syrup solids and/or glucooligosaccharides. These sweeteners are further intended to dissipate much of the bitter aftertaste associated with most low osmolarity oral rehydration solutions.

[0014] While this invention is satisfied by embodiments in many different forms, it is understood by those of skill in the art that the present disclosure is to be considered exemplary of the principles of the invention and is not intended to limit the invention to the embodiments illustrated or described. Accordingly, the inventors contemplate many related equivalent substitutions, and these inventions are not limited to the particular embodiments disclosed, but the embodiments are intended to cover all modifications that are within the spirit and scope of the invention as defined by the following appended claims.